Publicly traded U.S. companies have been slow to add minority directors over the past five years even as women grabbed a greater share of board seats during that period, a comprehensive study to be released on Monday shows. Across the Russell 3000, a broad index of U.S. companies, 29% now have two or more ethnically diverse directors, 7 percentage points more than in 2016, according to the new data from ISS ESG, an arm of Institutional Shareholder Services, scheduled to be presented at a conference on Monday. By contrast 66% of those boards now have 2 or more women, 27 percentage points more than in 2016, ISS found.

Publicly traded U.S. companies have been slow to add minority directors over the past five years even as women grabbed a greater share of board seats during that period, a comprehensive study to be released on Monday shows. Across the Russell 3000, a broad index of U.S. companies, 29% now have two or more ethnically diverse directors, 7 percentage points more than in 2016, according to the new data from ISS ESG, an arm of Institutional Shareholder Services, scheduled to be presented at a conference on Monday. By contrast 66% of those boards now have 2 or more women, 27 percentage points more than in 2016, ISS found.

In the forests and on remote offshore islands of Taiwan, a group of conservationists are racing to collect as many rare plant species as they can before they are lost to climate change and human encroachment. Overseen by the Dr. Cecilia Koo Botanic Conservation Centre, the plant hunters are scouring sub-tropical Taiwan for as many rare plant samples as they can find, from the rugged eastern coast around Taitung to Dongyin, in the Matsu archipelago. Industrialised Taiwan is best known for its mass production of technological goods.

In the forests and on remote offshore islands of Taiwan, a group of conservationists are racing to collect as many rare plant species as they can before they are lost to climate change and human encroachment. Overseen by the Dr. Cecilia Koo Botanic Conservation Centre, the plant hunters are scouring sub-tropical Taiwan for as many rare plant samples as they can find, from the rugged eastern coast around Taitung to Dongyin, in the Matsu archipelago. Industrialised Taiwan is best known for its mass production of technological goods.

Concern about climate change is growing, but there are big differences about the need for rapid action.

A humpback whale has found its way back to sea weeks after getting lost in a murky, crocodile-infested river in northern Australia, while an estimated 270 pilot whales became stranded in the country's south. There have been no previous recorded sightings of whales in remote East Alligator River in the Northern Territory’s World Heritage-listed Kakadu National Park, and no one can explain why at least three of the blue water mammals ventured so deep inland in a river with little visibility. In a more common phenomenon, about 270 pilot whales were reported stranded Monday on sandbars off Australia’s southern island of Tasmania state.

A Canadian company debuts a powerful new capability to monitor the potent greenhouse gas.

The Guardian's research was based on monitoring six popular pages that posted anti-vaccine messages.

Thousands of starfish washed up on Navarre Beach after Hurricane Sally, a grim parting gift from the tropical cyclone that devastated the Florida Panhandle earlier this week.

The fall equinox happens on Tuesday. Here's how the equinox works, according to a planetary scientist.

Once sunlight hit the ground, the seeds and rootstock of native grasses and wildflowers that had lain dormant for decades began to spring to life. The area was originally part of vast patchwork of Southern grasslands that today hang on only in tiny remnants, many times in rights-of-way next to roads or under power lines. In Tennessee, where the pine trees were cleared, wildlife officials now maintain about 4,000 acres of grassland in the Catoosa Wildlife Management Area with controlled low-temperature burns.

The median length of time that patients given the drug sotorasib lived before their disease worsened was 6.3 months for lung cancer patients and 4 months for colorectal cancer patients, the company said. Patients in the Phase I trial involving several types of cancer were treated with once daily sotorasib. The oral medication is designed to target a mutated form of a gene known as KRAS that occurs in about 13% of non-small cell lung cancers (NSCLC), the most common type of lung cancer.

Aurorae happen on other planets, too, as charged particles from the sun surge through the solar system.

In August, the CDC reported that 94% of Americans who died of COVID-19 had underlying conditions. But that doesn't mean the virus only killed 6%.

The head of the Russian space agency Roscosmos, Dmitry Rogozin, also said the country plans to send its own mission to Venus.

America's worsening climate change problem is as polarized as its politics. The already parched West is getting drier and suffering deadly wildfires because of it, while the much wetter East keeps getting drenched in mega-rainfall events, some hurricane related and others not. Climate change is magnifying both extremes, but it may not be the only factor, several scientists told The Associated Press.

Space Hero, Inc., a US-based production company, has announced plans to produce a reality show that would send one person into space in 2023.

Bristol Myers Squibb Co's cancer immunotherapy Opdivo in combination with Exelixis Inc's Cabometyx reduced the risk of death by 40% in previously untreated patients with advanced kidney cancer, according to data from a late-stage study to be presented on Saturday. The drug combination also doubled patients' median length of time before their cancer began to worsen to 16.6 months compared to progression-free survival of 8.3 months for patients treated with the chemotherapy sunitinib, an older Pfizer Inc drug sold under the brand name Sutent. "There is no doubt in my mind that this will be a major player" as an initial treatment for advanced kidney cancer, said lead researcher Dr. Toni Choueiri from Dana-Farber Cancer Institute in Boston.

Bristol Myers Squibb Co's cancer immunotherapy Opdivo in combination with Exelixis Inc's Cabometyx reduced the risk of death by 40% in previously untreated patients with advanced kidney cancer, according to data from a late-stage study to be presented on Saturday. The drug combination also doubled patients' median length of time before their cancer began to worsen to 16.6 months compared to progression-free survival of 8.3 months for patients treated with the chemotherapy sunitinib, an older Pfizer Inc drug sold under the brand name Sutent. "There is no doubt in my mind that this will be a major player" as an initial treatment for advanced kidney cancer, said lead researcher Dr. Toni Choueiri from Dana-Farber Cancer Institute in Boston.

Coronavirus "long-haulers" are still experiencing symptoms like fevers, brain fog, memory loss, nosebleeds, shortness of breath, and blurry vision.